FDA is going to release a list of "surrogate endpo
Post# of 72435
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
https://endpts.com/fda-to-release-list-of-sur...20oncology
Quote:
“This mirrors the FDA’s internal analysis, where we’ve found that Phase 1 trials that are based on an enrichment design – in other words, trials where the patients are selected for a treatment based on how their tumors express a specific biomarker — are associated with a significantly higher probability of demonstrating a clinical benefit than those that are not,” he added.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)